Submit Deal

CALLIO THERAPEUTICS

HQ - Singapore

Summary

Callio Therapeutics is a biotechnology company involved in the development of multi-payload antibody-drug conjugates for the cancer treatment sector.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 149 M

Avg. Deal Size£ 149 M

Market Context

Senior Management

Sort

Target: CALLIO THERAPEUTICS

Bidder: OMEGA FUNDS

13 Service Providers

26 Dealmakers

£ 148 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy